FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316783908> ?p ?o ?g. }

• W2316783908 endingPage "186" @default.
• W2316783908 startingPage "180" @default.
• W2316783908 abstract "Effective treatment methods for human leukemia are under development, but so far none of them have been found to be completely satisfactory. It was recently reported that palladium complexes have significant anticancer activity as well as lower toxicity compared with some clinically used chemotherapeutics. The anticancer activities of two novel palladium(II) complexes, [Pd(sac)(terpy)](sac)·4H2O and [PdCl(terpy)](sac)·2H2O, were tested against three human leukemia cell lines, Jurkat, MOLT-4, and THP-1, in comparison with cisplatin and adriamycin. The cytotoxic effect of the drugs was determined using the MTT assay. Cell death was assessed using fluorescein isothiocyanate-annexin/propidium iodide staining for flow cytometry. Furthermore, p53 phosphorylation, poly(ADP-ribose) polymerase cleavage, and Bax and Bcl-2 mRNA levels were examined to elucidate the mechanism of cell death induction. Both complexes exhibited a significant dose-dependent antigrowth effect in vitro. The complexes predominately induced apoptosis, but necrosis was also observed. In-vitro results have shown that palladium(II) complexes may be regarded as potential anticancer agents for treating human leukemia. Therefore, further analysis to determine the putative mechanism of action and in-vivo studies on animal models are warranted." @default.
• W2316783908 created "2016-06-24" @default.
• W2316783908 creator A5034936703 @default.
• W2316783908 creator A5043992959 @default.
• W2316783908 creator A5047890987 @default.
• W2316783908 creator A5063415883 @default.
• W2316783908 creator A5073108236 @default.
• W2316783908 creator A5076291391 @default.
• W2316783908 creator A5079001760 @default.
• W2316783908 date "2015-02-01" @default.
• W2316783908 modified "2023-09-25" @default.
• W2316783908 title "Cytotoxic activity of novel palladium-based compounds on leukemia cell lines" @default.
• W2316783908 cites W1730021373 @default.
• W2316783908 cites W1965405617 @default.
• W2316783908 cites W1969285468 @default.
• W2316783908 cites W1977201728 @default.
• W2316783908 cites W1986203922 @default.
• W2316783908 cites W2000678326 @default.
• W2316783908 cites W2008785144 @default.
• W2316783908 cites W2013886789 @default.
• W2316783908 cites W2019418370 @default.
• W2316783908 cites W2022316171 @default.
• W2316783908 cites W2026383707 @default.
• W2316783908 cites W2045552152 @default.
• W2316783908 cites W2066105236 @default.
• W2316783908 cites W2097607581 @default.
• W2316783908 cites W2122176664 @default.
• W2316783908 cites W2126783853 @default.
• W2316783908 cites W2133858723 @default.
• W2316783908 cites W2151273858 @default.
• W2316783908 cites W2156299289 @default.
• W2316783908 cites W2166346942 @default.
• W2316783908 doi "https://doi.org/10.1097/cad.0000000000000174" @default.
• W2316783908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25280061" @default.
• W2316783908 hasPublicationYear "2015" @default.
• W2316783908 type Work @default.
• W2316783908 sameAs 2316783908 @default.
• W2316783908 citedByCount "25" @default.
• W2316783908 countsByYear W23167839082015 @default.
• W2316783908 countsByYear W23167839082016 @default.
• W2316783908 countsByYear W23167839082017 @default.
• W2316783908 countsByYear W23167839082018 @default.
• W2316783908 countsByYear W23167839082019 @default.
• W2316783908 countsByYear W23167839082020 @default.
• W2316783908 countsByYear W23167839082021 @default.
• W2316783908 countsByYear W23167839082023 @default.
• W2316783908 crossrefType "journal-article" @default.
• W2316783908 hasAuthorship W2316783908A5034936703 @default.
• W2316783908 hasAuthorship W2316783908A5043992959 @default.
• W2316783908 hasAuthorship W2316783908A5047890987 @default.
• W2316783908 hasAuthorship W2316783908A5063415883 @default.
• W2316783908 hasAuthorship W2316783908A5073108236 @default.
• W2316783908 hasAuthorship W2316783908A5076291391 @default.
• W2316783908 hasAuthorship W2316783908A5079001760 @default.
• W2316783908 hasConcept C121332964 @default.
• W2316783908 hasConcept C150903083 @default.
• W2316783908 hasConcept C153911025 @default.
• W2316783908 hasConcept C154317977 @default.
• W2316783908 hasConcept C171122931 @default.
• W2316783908 hasConcept C179464577 @default.
• W2316783908 hasConcept C185592680 @default.
• W2316783908 hasConcept C190283241 @default.
• W2316783908 hasConcept C202751555 @default.
• W2316783908 hasConcept C203014093 @default.
• W2316783908 hasConcept C207001950 @default.
• W2316783908 hasConcept C2775934118 @default.
• W2316783908 hasConcept C2776090121 @default.
• W2316783908 hasConcept C2776694085 @default.
• W2316783908 hasConcept C2777019933 @default.
• W2316783908 hasConcept C2778239845 @default.
• W2316783908 hasConcept C2778461978 @default.
• W2316783908 hasConcept C31573885 @default.
• W2316783908 hasConcept C54355233 @default.
• W2316783908 hasConcept C553184892 @default.
• W2316783908 hasConcept C55493867 @default.
• W2316783908 hasConcept C62520636 @default.
• W2316783908 hasConcept C81885089 @default.
• W2316783908 hasConcept C86803240 @default.
• W2316783908 hasConcept C88634738 @default.
• W2316783908 hasConcept C8891405 @default.
• W2316783908 hasConcept C91881484 @default.
• W2316783908 hasConceptScore W2316783908C121332964 @default.
• W2316783908 hasConceptScore W2316783908C150903083 @default.
• W2316783908 hasConceptScore W2316783908C153911025 @default.
• W2316783908 hasConceptScore W2316783908C154317977 @default.
• W2316783908 hasConceptScore W2316783908C171122931 @default.
• W2316783908 hasConceptScore W2316783908C179464577 @default.
• W2316783908 hasConceptScore W2316783908C185592680 @default.
• W2316783908 hasConceptScore W2316783908C190283241 @default.
• W2316783908 hasConceptScore W2316783908C202751555 @default.
• W2316783908 hasConceptScore W2316783908C203014093 @default.
• W2316783908 hasConceptScore W2316783908C207001950 @default.
• W2316783908 hasConceptScore W2316783908C2775934118 @default.
• W2316783908 hasConceptScore W2316783908C2776090121 @default.
• W2316783908 hasConceptScore W2316783908C2776694085 @default.
• W2316783908 hasConceptScore W2316783908C2777019933 @default.
• W2316783908 hasConceptScore W2316783908C2778239845 @default.
• W2316783908 hasConceptScore W2316783908C2778461978 @default.

• next